MENU
+Compare
BMNDF
Stock ticker: OTC
AS OF
Jun 25 closing price
Price
$0.10
Change
-$0.00 (-0.00%)
Capitalization
7.75M

BMNDF BIOMIND LABS INC. Forecast, Technical & Fundamental Analysis

Biomind Labs Inc is a biotech Research and Development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions... Show more

BMNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BMNDF with price predictions
Jul 03, 2025

BMNDF in downward trend: 10-day moving average moved below 50-day moving average on June 16, 2025

The 10-day moving average for BMNDF crossed bearishly below the 50-day moving average on June 16, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

BMNDF moved below its 50-day moving average on June 16, 2025 date and that indicates a change from an upward trend to a downward trend.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Momentum Indicator moved above the 0 level on July 01, 2025. You may want to consider a long position or call options on BMNDF as a result. In of 27 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMNDF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (16.678). P/E Ratio (0.000) is within average values for comparable stocks, (58.763). BMNDF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.315). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (269.614).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BMNDF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
BMNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Camino Saravia s/n
Phone
+589 92251500
Employees
5
Web
https://www.biomindlabs.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PEGA54.031.37
+2.60%
Pegasystems Inc
SGHT4.210.05
+1.20%
Sight Sciences
PBR13.060.11
+0.85%
Petroleo Brasileiro Sa-Petrobras ADS (REP 1 Common Share)
XLO0.700.01
+0.72%
Xilio Therapeutics
LESL0.42-0.02
-4.81%
Leslie's

BMNDF and Stocks

Correlation & Price change

A.I.dvisor tells us that BMNDF and APM have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BMNDF and APM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMNDF
1D Price
Change %
BMNDF100%
N/A
APM - BMNDF
27%
Poorly correlated
+4.18%
LVTX - BMNDF
23%
Poorly correlated
+0.76%
PHGE - BMNDF
22%
Poorly correlated
N/A
CYDY - BMNDF
12%
Poorly correlated
+5.56%
FAMDF - BMNDF
4%
Poorly correlated
-23.08%
More